Part 1: Principles & Clinical Advances of I-O

* 1. How knowledgeable are you on the ways in which immuno-oncology agents exert their actions to fight cancer?

* 2. Which of the following statements is correct?

* 3. If our immune system is able to detect and destroy abnormal tumour cells, how do these cells develop into cancer?

* 4. Which known molecules contribute to T-cell inhibition?

* 5. How many immune checkpoint inhibitors are currently approved (as of July 2017) by Health Canada to treat cancer?

* 6. Select a way in which I-O agents differ from standard chemotherapy?